Know Cancer

or
forgot password

Randomized, Placebo-Controlled, Phase IIB Evaluation of Cyclooxygenase-2 Activity in Surgically Resected Primary Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib


Phase 2
19 Years
N/A
Not Enrolling
Both
Colorectal Adenoma, Colorectal Carcinoma

Thank you

Trial Information

Randomized, Placebo-Controlled, Phase IIB Evaluation of Cyclooxygenase-2 Activity in Surgically Resected Primary Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib


Inclusion Criteria:



- Colon mass

Exclusion Criteria:

- Allergic to aspirin

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Principal Investigator

Martin J Heslin, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alabama at Birmingham

Authority:

United States: Institutional Review Board

Study ID:

F001228004

NCT ID:

NCT00582660

Start Date:

December 2001

Completion Date:

June 2008

Related Keywords:

  • Colorectal Adenoma
  • Colorectal Carcinoma
  • Adenoma
  • Carcinoma
  • Colorectal Neoplasms

Name

Location

University of Alabama at Birmingham Birmingham, Alabama  35294-3300